gvtcx

PHE - Corporate - Antimicrobial Resistance on Common Surgical Procedures

Public Health England Published 13 Jan 2020 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 75122000
Deadline13 Dec 2019
Contract start13 Jan 2020
Contract end31 Mar 2020
SME suitableYes
OCIDocds-b5fd17-efcde513-32f8-4a69-86c6-fd203272171c

Award

SupplierValueDateStatus
University of York £95,488 13 Jan 2020 active

description

The main goal of this work is to quantify the major so-called- 'secondary effects' of ABR that are predicted to rise as resistance rises in the population.To quantify the indirect cost of ABR on surgical interventions, the project will establish a prioritised list of surgical interventions that would be affected by ABR and how likely the risk of an untreatable infection would have to be for surgery to be avoided for a range of surgical categories.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
13 Jan 2020 Award (award) · affd3394-5c46-4f5f-8154-08b1dd466a9d-336723

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.